Nucleix
Latest round
- Seed
Last raised
- May 2016
Total raised
- $3M
Investors
- 2
About Nucleix
Nucleix is a diagnostic solutions provider established in 2008 in Rehovot, Israel. The company was founded by Adam Wasserstrom and Danny Frumkin, with Chris Hibberd currently serving as CEO.Nucleix specializes in innovative diagnostic solutions aimed at early cancer detection, including its flagship product, Bladder EpiCheck®. This non-invasive test detects both primary and recurrent bladder cancer and upper tract urinary cancer, thus serving as a vital tool for at-risk patients. Bladder EpiCheck® has received CE marking for sale in Europe and FDA clearance for monitoring bladder cancer recurrence in the United States.Nucleix's revenue model is centered around the sales of its diagnostic products, particularly Bladder EpiCheck®, which plays a crucial role in monitoring non-muscle invasive bladder cancer recurrence. The company engages in direct transactions with healthcare providers, hospitals, and laboratories, ensuring a streamlined delivery of its testing solutions.00 mn to advance the development of new products, including a blood test for early-stage lung cancer detection. The company is also targeting expansion into new markets, with a focus on broadening its presence in Europe and North America by 2025.
Who invested in Nucleix
2 investors across 1 round
See all investors in Nucleix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 23, 2016
Amount
$3M
Investors
Questions about Nucleix
Who invested in Nucleix?
Nucleix has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nucleix raised?
Nucleix has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nucleix last raise money?
Nucleix's most recent round on record is a Seed, in May 2016.
What does Nucleix do?
Nucleix is a diagnostic solutions provider established in 2008 in Rehovot, Israel.
Where is Nucleix headquartered?
Nucleix is headquartered in Rehovot, Israel.
Which VCs invest in companies like Nucleix?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back healthcare specialists companies at Nucleix's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Seed
Raising like Nucleix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.